You have 9 free searches left this month | for more free features.

Androgenic blockade

Showing 1 - 25 of 1,537

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Adenocarcinoma Trial in France (Firmagon)

Recruiting
  • Prostate Adenocarcinoma
  • Clermont-Ferrand, France
  • +5 more
Mar 14, 2022

Androgenetic Alopecia Trial in Beijing (-Q2W, HMI-115-120mg-Q4W, HMI-115-240mg-Q4W)

Recruiting
  • Androgenetic Alopecia
  • placebo-Q2W
  • +3 more
  • Beijing, Beijing, China
    Peking University People's Hospital
Nov 3, 2023

AGA Trial in Zhejiang (CU-40101)

Not yet recruiting
  • AGA
  • Zhejiang, Hangzhou, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jun 26, 2022

Androgenic Alopecia Trial in New Haven (Tattoo machine)

Completed
  • Androgenic Alopecia
  • Tattoo machine
  • New Haven, Connecticut
    Yale University
Dec 7, 2022

Androgenic Alopecia Trial in Minneapolis (Venus Glow)

Recruiting
  • Androgenic Alopecia
  • Venus Glow
  • Minneapolis, Minnesota
    University of Minnesota
Jun 20, 2022

Chronic Limb-Threatening Ischemia Trial in Košice (lumbar sympathetic blockade)

Recruiting
  • Chronic Limb-Threatening Ischemia
  • lumbar sympathetic blockade
  • Košice, Slovakia
    Europainclinics
Oct 26, 2023

Rocuronium vs Cis-atracurium: Do Rocuronium Still 'ROCKS' In

Recruiting
  • Neuromuscular Blockade
  • +5 more
  • Rocuronium Bromide 10 MG/ML
  • Nimbex 10 MG in 5 ML Injection
  • Kuala Lumpur, Malaysia
    Institut Jantung Negara
Oct 22, 2023

Safety and Efficacy, Scalp Nerve Block Trial (a modified auriculotemporal nerve blockade, Traditional auriculotemporal nerve

Not yet recruiting
  • Safety and Efficacy
  • Scalp Nerve Block
  • a modified auriculotemporal nerve blockade
  • Traditional auriculotemporal nerve blockade
  • (no location specified)
Sep 23, 2022

Hip Dysplasia, Hip Injuries, Hip Fractures Trial (Pericapsular nerve group block using 0.2% ropivacaine, Erector Spinae Plane

Not yet recruiting
  • Hip Dysplasia
  • +3 more
  • Pericapsular nerve group block using 0.2% ropivacaine
  • +2 more
  • (no location specified)
Oct 11, 2023

Bariatric Surgery Candidate, Weight Loss, Surgery Trial in Galway (Bilateral Erector Spinae Plane Block, Abdominal Wall Blocks)

Recruiting
  • Bariatric Surgery Candidate
  • +2 more
  • Bilateral Erector Spinae Plane Block
  • Abdominal Wall Blocks
  • Galway, Ireland
    University Hospital Galway
May 1, 2023

Neuromuscular Blockade, Critical Illness, Neurologic Findings Trial (Sugammadex, Neostigmine)

Not yet recruiting
  • Neuromuscular Blockade
  • +2 more
  • (no location specified)
Aug 14, 2023

NSCLC (NSCLC) Trial (Alirocumab and Cemiplimab)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Alirocumab and Cemiplimab
  • (no location specified)
Jan 31, 2023

Psoriasis of Scalp Trial in San Francisco (Guselkumab)

Recruiting
  • Psoriasis of Scalp
  • San Francisco, California
    University of California San Francisco
May 4, 2023

Atopic Dermatitis Trial in San Francisco (Dupilumab)

Recruiting
  • Atopic Dermatitis
  • San Francisco, California
    University of California, San Francisco
May 4, 2023

Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Brentuximab Vedotin 50 MG [Adcetris]
  • Leon, Guanajuato, Mexico
    Hospital Regional Alta Especialidad Bajio
Oct 24, 2022

Using Kine-myography vs Electromyography.

Not yet recruiting
  • Neuromuscular Blockade
  • Residual Neuromuscular Blockade
    • Ústí Nad Labem, Ústí Nad Labem Region, Czechia
      Masarykova Nemocnice v Ústí nad Labem, Krajská Zdravotní a.s.
    Aug 7, 2023

    Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • Brasschaat, Belgium
    • +53 more
    Nov 29, 2022

    Emergence Delirium, Strabismus, Pediatric ALL Trial (Bridion 200 MG in 2 ML Injection, Neostigmine Methylsulfate)

    Not yet recruiting
    • Emergence Delirium
    • +2 more
    • Bridion 200 MG in 2 ML Injection
    • Neostigmine Methylsulfate
    • (no location specified)
    Sep 6, 2023

    ACL, Postoperative Pain Trial in Philadelphia (Exparel 30 mL, 0.5% bupivacaine, Dexamethasone)

    Enrolling by invitation
    • ACL
    • Postoperative Pain
    • Exparel 30 mL
    • +3 more
    • Philadelphia, Pennsylvania
      Rothman Orthopaedic Institute
    Aug 22, 2023

    Androgenic Alopecia Trial in United States (Keravive by Hydrafacial Treatments)

    Completed
    • Androgenic Alopecia
    • Keravive by Hydrafacial Treatments
    • Los Angeles, California
    • +3 more
    Oct 27, 2023

    Male Androgenetic Alopecia Trial in Madrid (Dutasteride, Placebo)

    Recruiting
    • Male Androgenetic Alopecia
    • Madrid, Spain
      Hospital Ramón y Cajal
    Oct 25, 2022

    Pain, Postoperative, Nausea, Postoperative, Vomiting, Postoperative Trial (Local anesthetic injection Bupivacaine plus

    Not yet recruiting
    • Pain, Postoperative
    • +4 more
    • Local anesthetic injection Bupivacaine plus dexamethasone
    • +2 more
    • (no location specified)
    Nov 13, 2023

    Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab, Camrelizumanb plus TPF)

    Active, not recruiting
    • Oral Squamous Cell Carcinoma
    • Wuhan, Hubei, China
      Hospital of Stomatology, Wuhan University
    Aug 17, 2022

    Nerve Block, Efficiency, Sciatic Nerve Trial in Mogilev (sciatic nerve blockade under ultrasound control with a peripheral nerve

    Completed
    • Nerve Block
    • +3 more
    • sciatic nerve blockade under ultrasound control with a peripheral nerve stimulator
    • sciatic nerve blockade under ultrasound control without a peripheral nerve stimulator
    • Mogilev, Belarus
      Mogilev Regional Clinical Hospital
    Aug 8, 2022

    Primary Aldosteronism, Endocrine Hypertension Trial (Cinnarizine, NIFEdipine ER)

    Not yet recruiting
    • Primary Aldosteronism
    • Endocrine Hypertension
    • (no location specified)
    Jan 12, 2023